Bayer is a life science company that specializes in the areas of health care and agriculture.
Bayer is an enterprise with core competencies in the life science fields of healthcare and nutrition. They design their products and services to help people and the planet thrive by supporting efforts to address unprecedented challenges. Their businesses include pharmaceuticals, consumer health, and crop science. They focus on developing and commercializing products and solutions based on scientific knowledge.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Nov 8, 2022 | Grant | $12M | 1 |
![]() |
— | Detail |
Apr 17, 2018 | Post-IPO Equity | €3B | 1 |
![]() |
— | Detail |
Oct 2, 2009 | IPO | — | — | — | — | Detail |
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Jun 20, 2022
![]() |
Seed | — | Analytics | — |
Mar 1, 2021
![]() |
Series Unknown | R$18M | Agriculture | — |
Nov 17, 2020
![]() |
Series Unknown | — | Health Care | — |
Aug 24, 2020
![]() |
Series C | $34.70M | Apps | Yes |
Feb 27, 2020
![]() |
Corporate Round | $55M | Biotechnology | — |
Investor Name | Lead Investor | Funding Round |
---|---|---|
![]() |
Yes | Grant |
![]() |
Yes | Post-IPO Equity |
Bayer has had 2 exits. Bayer most notable exits include Covercress , BlueRock Therapeutics
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Aug 1, 2022 | Covercress | M&A | Animal Feed | Detail |
Aug 8, 2019 | BlueRock Therapeutics | M&A | Biopharma | Detail |
Bayer has acquired 16 organizations. Their most recent acquisition was Zeptosens on Mar 9, 2005. They acquired Zeptosens for 0.
Date
Company Name
|
Industry | Acquisition Type | Price | |
---|---|---|---|---|
Mar 9, 2005
![]() |
Biotechnology | — | — | Detail |
Feb 13, 2006
![]() |
Agriculture | — | — | Detail |
Mar 11, 2010
![]() |
Electronics | acquisition | — | Detail |
Jul 1, 2012
![]() |
Agriculture | acquisition | $ 425M | Detail |
Dec 19, 2013
![]() |
Biotechnology | acquisition | $ 2.90B | Detail |